The PDP of the RSF model showed that unfavorable clinical factors, including a high AFP, Child–Pugh B, the presence of PVTT or metastasis, advanced BCLC stage, a large tumor size, and an elevated AST, were consistently associated with poorer survival probabilities. This evidence concerns the gene AFP and neoplasm.